サマリー

世界のバイオ医薬品市場規模は、2022年に2,736億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に10.1%の成長率（CAGR）を示し、2028年までに480.0億米ドルに達すると予測しています。

バイオ医薬品は、ヒト、動物、微生物などの生物学的資源から抽出され、あるいは遺伝子組換え技術によって合成された複合医薬品です。糖質、タンパク質、核酸、生きた細胞、組織、さまざまな成分の複合体から構成されています。ワクチン、血液成分、体細胞・組織、アレルゲン、細胞療法・遺伝子療法・組換え治療用タンパク質に使用される生細胞の製造を支援するものである。また、がん、糖尿病、心血管疾患、免疫疾患、その他の健康問題の治療を支援し、標的治療と少ない副作用を提供します。

バイオ医薬品の市場動向：
免疫血清、ホルモン、サイトカイン、酵素、モノクローナル抗体など、バイオ医薬品の利用が拡大していることが、現在、市場を牽引する重要な要因の一つとなっています。さらに、関節リウマチ、多発性硬化症、心血管疾患の治療用として、世界中でモノクローナル抗体の需要が高まっています。また、タバコやアルコールの過剰摂取、栄養不足、運動不足による慢性疾患の有病率の上昇も、市場の成長を後押ししています。さらに、他の医薬品や医療機器が利用できないさまざまな疾患の治療に、細胞や遺伝子を利用したバイオ医薬品の利用が増加しており、業界の投資家に有利な成長機会を提供しています。さらに、主要な市場関係者は、治療不可能な疾患を治療するための革新的な医薬品を導入するために、研究開発（R&D）活動に幅広く投資しています。これは、バイオ医薬品の利点に関する大衆の意識の高まりと相まって、市場にプラスの影響を及ぼしています。また、老年人口の増加や医療産業の発展も、バイオ医薬品の需要を喚起しています。さらに、がん細胞の増殖と生存に関与する特定の遺伝子やタンパク質を標的とする標的療法の需要が高まっていることも、市場の成長を後押ししています。

主要な市場セグメント：

IMARC Groupは、世界のバイオ医薬品市場レポートの各サブセグメントにおける主要トレンドの分析、および2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、適応症とクラスに基づいて市場を分類しています。

表示によるブレークアップ：

自己免疫疾患
オンコロジー
メタボリックシンドローム
その他

現在、環境負荷の増大と個人の食習慣の変化により、自己免疫疾患が市場を席巻しています。

クラス別内訳：

リコンビナントタンパク質
モノクローナル抗体
精製蛋白質

現在、モノクローナル抗体が最大のシェアを占めているのは、治療用途が拡大していること、単一のエピトープに対する特異性が高く、交差反応性が低いことが理由です。

地域別構成比：

北アメリカ
ユーエスエー
カナダ
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
ヨーロッパ
ドイツ
フランス
イタリア
スペイン
イギリス
ロシア
トルコ
アジア太平洋
日本
中国
オーストラリア
南朝鮮
インド
インドネシア

現在、北米は世界最大のバイオ医薬品市場を形成しています。さらに、米国とカナダに区分される。

本レポートで回答した主な質問

1.2022年のバイオ医薬品の世界市場規模は？
2.2023-2028年のバイオ医薬品の世界市場の予想成長率は？
3.バイオ医薬品の世界市場を牽引する重要な要因は何か？
4.COVID-19が世界のバイオ医薬品市場に与えた影響とは？
5.世界のバイオ医薬品市場の適応症に基づく内訳はどうなっていますか？
6.世界のバイオ医薬品市場のクラス別の内訳は？
7.バイオ医薬品の世界市場における主要地域は？
8.バイオ医薬品の世界市場における主要なプレイヤー/企業は？

ページTOPに戻る

目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
5 Global Biopharmaceutical Market
5.1 Market Performance and Forecast
5.1.1 Current Performance (2017-2022)
5.1.2 Market Forecast (2023-2028)
5.2 Impact of COVID-19
5.3 Market by Region
5.3.1 Current Performance (2017-2022)
5.3.2 Market Forecast (2023-2028)
5.4 Market by Indication
5.4.1 Autoimmune Diseases
5.4.2 Oncology
5.4.3 Metabolic Disorders
5.4.4 Others
5.5 Market by Class
5.5.1 Recombinant Proteins
5.5.1.1 Current Performance (2017-2022)
5.5.1.2 Market Forecast (2023-2028)
5.5.2 Monoclonal Antibodies
5.5.2.1 Current Performance (2017-2022)
5.5.2.2 Market Forecast (2023-2028)
5.5.3 Purified Proteins
5.5.3.1 Current Performance (2017-2022)
5.5.3.2 Market Forecast (2023-2028)
5.6 Competitive Landscape
5.6.1 Top Biopharmaceutical Players
5.6.2 Top Biopharmaceutical Drugs
5.7 Value Chain Analysis
5.8 Porter’s Five Forces Analysis
5.8.1 Overview
5.8.2 Bargaining Power of Buyers
5.8.3 Bargaining Power of Suppliers
5.8.4 Degree of Rivalry
5.8.5 Threat of New Entrants
5.8.6 Threat of Substitutes
6 North America
6.1 United States
6.1.1 Market Performance (2017-2022)
6.1.2 Market by Class
6.1.2.1 Recombinant Proteins
6.1.2.2 Monoclonal Antibodies
6.1.2.3 Purified Proteins
6.1.3 Top Players
6.1.4 Market Forecast (2023-2028)
6.2 Canada
6.2.1 Market Performance (2017-2022)
6.2.2 Market by Class
6.2.2.1 Recombinant Proteins
6.2.2.2 Monoclonal Antibodies
6.2.2.3 Purified Proteins
6.2.3 Top Players
6.2.4 Market Forecast (2023-2028)
7 Latin America
7.1 Mexico
7.1.1 Market Performance (2017-2022)
7.1.2 Market by Class
7.1.2.1 Recombinant Proteins
7.1.2.2 Monoclonal Antibodies
7.1.2.3 Purified Proteins
7.1.3 Top Players
7.1.4 Market Forecast (2023-2028)
7.2 Brazil
7.2.1 Market Performance (2017-2022)
7.2.2 Market by Class
7.2.2.1 Recombinant Proteins
7.2.2.2 Monoclonal Antibodies
7.2.2.3 Purified Proteins
7.2.3 Top Players
7.2.4 Market Forecast (2023-2028)
7.3 Argentina
7.3.1 Market Performance (2017-2022)
7.3.2 Market by Class
7.3.2.1 Recombinant Proteins
7.3.2.2 Monoclonal Antibodies
7.3.2.3 Purified Proteins
7.3.3 Top Players
7.3.4 Market Forecast (2023-2028)
8 Europe
8.1 Germany
8.1.1 Market Performance (2017-2022)
8.1.2 Market by Class
8.1.2.1 Recombinant Proteins
8.1.2.2 Monoclonal Antibodies
8.1.2.3 Purified Proteins
8.1.3 Top Players
8.1.4 Market Forecast (2023-2028)
8.2 France
8.2.1 Market Performance (2017-2022)
8.2.2 Market by Class
8.2.2.1 Recombinant Proteins
8.2.2.2 Monoclonal Antibodies
8.2.2.3 Purified Proteins
8.2.3 Top Players
8.2.4 Market Forecast (2023-2028)
8.3 Italy
8.3.1 Market Performance (2017-2022)
8.3.2 Market by Class
8.3.2.1 Recombinant Proteins
8.3.2.2 Monoclonal Antibodies
8.3.2.3 Purified Proteins
8.3.3 Top Players
8.3.4 Market Forecast (2023-2028)
8.4 Spain
8.4.1 Market Performance (2017-2022)
8.4.2 Market by Class
8.4.2.1 Recombinant Proteins
8.4.2.2 Monoclonal Antibodies
8.4.2.3 Purified Proteins
8.4.3 Top Players
8.4.4 Market Forecast (2023-2028)
8.5 United Kingdom
8.5.1 Market Performance (2017-2022)
8.5.2 Market by Class
8.5.2.1 Recombinant Proteins
8.5.2.2 Monoclonal Antibodies
8.5.2.3 Purified Proteins
8.5.3 Top Players
8.5.4 Market Forecast (2023-2028)
8.6 Russia
8.6.1 Market Performance (2017-2022)
8.6.2 Market by Class
8.6.2.1 Recombinant Proteins
8.6.2.2 Monoclonal Antibodies
8.6.2.3 Purified Proteins
8.6.3 Top Players
8.6.4 Market Forecast (2023-2028)
8.7 Turkey
8.7.1 Market Performance (2017-2022)
8.7.2 Market by Class
8.7.2.1 Recombinant Proteins
8.7.2.2 Monoclonal Antibodies
8.7.2.3 Purified Proteins
8.7.3 Top Players
8.7.4 Market Forecast (2023-2028)
9 Asia Pacific
9.1 Japan
9.1.1 Market Performance (2017-2022)
9.1.2 Market by Class
9.1.2.1 Recombinant Proteins
9.1.2.2 Monoclonal Antibodies
9.1.2.3 Purified Proteins
9.1.3 Top Players
9.1.4 Market Forecast (2023-2028)
9.2 China
9.2.1 Market Performance (2017-2022)
9.2.2 Market by Class
9.2.2.1 Recombinant Proteins
9.2.2.2 Monoclonal Antibodies
9.2.2.3 Purified Proteins
9.2.3 Top Players
9.2.4 Market Forecast (2023-2028)
9.3 Australia
9.3.1 Market Performance (2017-2022)
9.3.2 Market by Class
9.3.2.1 Recombinant Proteins
9.3.2.2 Monoclonal Antibodies
9.3.2.3 Purified Proteins
9.3.3 Top Players
9.3.4 Market Forecast (2023-2028)
9.4 South Korea
9.4.1 Market Performance (2017-2022)
9.4.1.1 Recombinant Proteins
9.4.1.2 Monoclonal Antibodies
9.4.1.3 Purified Proteins
9.4.2 Top Players
9.4.3 Market Forecast (2023-2028)
9.5 India
9.5.1 Market Performance (2017-2022)
9.5.2 Market by Class
9.5.2.1 Recombinant Proteins
9.5.2.2 Monoclonal Antibodies
9.5.2.3 Purified Proteins
9.5.3 Top Players
9.5.4 Market Forecast (2023-2028)
9.6 Indonesia
9.6.1 Market Performance (2017-2022)
9.6.2 Market by Class
9.6.2.1 Recombinant Proteins
9.6.2.2 Monoclonal Antibodies
9.6.2.3 Purified Proteins
9.6.3 Top Players
9.6.4 Market Forecast (2023-2028)
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 AbbVie Inc.
11.3.2 Amgen Inc
11.3.3 Biogen Inc.
11.3.4 Eli Lilly and Company
11.3.5 F. Hoffmann-La Roche AG
11.3.6 Johnson & Johnson
11.3.7 Merck & Co. Inc.
11.3.8 Novo Nordisk A/S
11.3.9 Pfizer Inc.
11.3.10 Sanofi S.A

List of Figures

Figure 1: Global: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 2: Complexity of Biopharmaceuticals
Figure 3: Sources of Biopharmaceuticals
Figure 4: Global: Biopharmaceutical Market: Value Trends (in Billion US$), 2017-2022
Figure 5: Global: Biopharmaceutical Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 6: Global: Biopharmaceutical Market: Sales Share by Country (in %), 2022
Figure 7: Global: Biopharmaceutical Market Forecast: Sales Share by Country (in %), 2028
Figure 8: Global: Biopharmaceutical Market: Sales Share by Indication (in %), 2022
Figure 9: Global: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 10: Global: Biopharmaceutical Market Forecast: Sales by Class (in Million US$), 2023-2028
Figure 11: Global: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 12: Global: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 13: Global: Recombinant Proteins Market Forecast (in Million US$), 2023-2028
Figure 14: Global: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 15: Global: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 16: Global: Monoclonal Antibodies Market Forecast (in Million US$), 2023-2028
Figure 17: Global: Purified Proteins Market (in Million US$), 2017-2022
Figure 18: Global: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 19: Global: Purified Proteins Market Forecast (in Million US$), 2023-2028
Figure 20: Global: Biopharmaceutical Market: Sales Share of Top Biopharmaceuticals (in %)
Figure 21: Global: Biopharmaceutical Industry: Value Chain Analysis
Figure 22: Global: Biopharmaceutical Industry: Porter’s Five Forces Analysis
Figure 23: United States: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 24: United States: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 25: United States: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 26: United States: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 27: United States: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 28: United States: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 29: United States: Purified Proteins Market (in Million US$), 2017-2022
Figure 30: United States: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 31: United States: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 32: United States: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 33: United States: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 34: Canada: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 35: Canada: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 36: Canada: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 37: Canada: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 38: Canada: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 39: Canada: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 40: Canada: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 41: Canada: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 42: Canada: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 43: Mexico: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 44: Mexico: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 45: Mexico: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 46: Mexico: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 47: Mexico: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 48: Mexico: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 49: Mexico: Purified Proteins Market (in '000 US$), 2017-2022
Figure 50: Mexico: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 51: Mexico: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 52: Mexico: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 53: Brazil: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 54: Brazil: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 55: Brazil: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 56: Brazil: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 57: Brazil: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 58: Brazil: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 59: Brazil: Purified Proteins Market (in Million US$), 2017-2022
Figure 60: Brazil: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 61: Brazil: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 62: Brazil: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 63: Argentina: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 64: Argentina: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 65: Argentina: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 66: Argentina: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 67: Argentina: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 68: Argentina: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 69: Argentina: Purified Proteins Market (in Million US$), 2017-2022
Figure 70: Argentina: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 71: Argentina: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 72: Argentina: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 73: Germany: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 74: Germany: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 75: Germany: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 76: Germany: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 77: Germany: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 78: Germany: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 79: Germany: Purified Proteins Market (in Million US$), 2017-2022
Figure 80: Germany: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 81: Germany: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 82: Germany: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 83: Germany: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 84: France: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 85: France: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 86: France: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 87: France: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 88: France: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 89: France: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 90: France: Purified Proteins Market (in Million US$), 2017-2022
Figure 91: France: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 92: France: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 93: France: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 94: Italy: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 95: Italy: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 96: Italy: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 97: Italy: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 98: Italy: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 99: Italy: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 100: Italy: Purified Proteins Market (in Million US$), 2017-2022
Figure 101: Italy: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 102: Italy: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 103: Italy: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 104: Spain: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 105: Spain: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 106: Spain: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 107: Spain: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 108: Spain: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 109: Spain: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 110: Spain: Purified Proteins Market (in Million US$), 2017-2022
Figure 111: Spain: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 112: Spain: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 113: Spain: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 114: Spain: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 115: UK: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 116: UK: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 117: UK: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 118: UK: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 119: UK: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 120: UK: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 121: UK: Purified Proteins Market (in Million US$), 2017-2022
Figure 122: UK: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 123: UK: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 124: UK: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 125: UK: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 126: Russia: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 127: Russia: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 128: Russia: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 129: Russia: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 130: Russia: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 131: Russia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 132: Russia: Purified Proteins Market: (in Million US$), 2017-2022
Figure 133: Russia: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 134: Russia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 135: Russia: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 136: Russia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 137: Turkey: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 138: Turkey: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 139: Turkey: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 140: Turkey: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 141: Turkey: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 142: Turkey: Purified Proteins Market (in Million US$), 2017-2022
Figure 143: Turkey: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 144: Turkey: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 145: Turkey: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 146: Japan: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 147: Japan: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 148: Japan: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 149: Japan: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 150: Japan: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 151: Japan: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 152: Japan: Purified Proteins Market (in Million US$), 2017-2022
Figure 153: Japan: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 154: Japan: Biopharmaceutical Market Forecast: Value trend (in Million US$), 2023-2028
Figure 155: Japan: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 156: China: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 157: China: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 158: China: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 159: China: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 160: China: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 161: China: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 162: China: Purified Proteins Market: (in Million US$), 2017-2022
Figure 163: China: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 164: China: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 165: China: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 166: China: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 167: Australia: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 168: Australia: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 169: Australia: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 170: Australia: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 171: Australia: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 172: Australia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 173: Australia: Purified Proteins Market (in Million US$), 2017-2022
Figure 174: Australia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 175: Australia: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 176: Australia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 177: South Korea: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 178: South Korea: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 179: South Korea: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 180: South Korea: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 181: South Korea: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 182: South Korea: Monoclonal Antibodies Market: Sales Share by Class, (in %), 2022
Figure 183: South Korea: Purified Proteins Market (in Million US$), 2017-2022
Figure 184: South Korea: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 185: South Korea: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 186: South Korea: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 187: South Korea: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 188: India: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 189: India: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 190: India: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 191: India: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 192: India: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 193: India: Purified Proteins Market (in Million US$), 2017-2022
Figure 194: India: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 195: India: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 196: India: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 197: Indonesia: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 198: Indonesia: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 199: Indonesia: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 200: Indonesia: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 201: Indonesia: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 202: Indonesia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 203: Indonesia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 204: Indonesia: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 205: Indonesia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 206: Global: Share of Biopharmaceuticals & Small Molecule Drugs Among the Top Ten Selling Drugs (in %), 2001 & 2022
Figure 207: Using a Different Manufacturing Process Makes it Extremely Difficult for Biosimilars to be Equivalent to Originator Products
Figure 208: Marked Differences Between Biosimilar and Branded Biopharmaceuticals When a Different Production Process was Used
Figure 209: Transition Probabilities of Biopharmaceuticals & Small Molecule Drugs in Clinical Phases, (in %)
Figure 210: Comparison of the Average Annual Cost of Therapy Using Biopharmaceuticals and Small Molecule Drugs (in US$)
Figure 211: Emerging Biopharmaceutical Market Forecast (in Million US$), 2022 & 2028
Figure 212: Developed Biopharmaceutical Market Forecast (in Million US$), 2022 & 2028
Figure 213: Breakup of Biopharmaceuticals and Small Molecule Drugs Receiving FDA Approval (in Numbers), 2002-2022
Figure 214: A Comparison of the Costs Incurred While Developing Biopharmaceuticals and Small Molecule Drugs (in Million US$)
Figure 215: Comparison of the Research & Development Times for Biopharmaceuticals & Small Molecule Drugs (in Months)

List of Tables

Table 1: Global: Biopharmaceutical Market: Definition & Segmentation
Table 2: Global: Biopharmaceutical Market: SWOT Analysis
Table 3: Global: Biopharmaceutical Market Forecast: Sales by Region (in Million US$), 2022 & 2028
Table 4: Differences Between Small Molecule Drugs & Biopharmaceuticals
Table 5: Complexity of Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
Table 6: Global: Biopharmaceutical Market: Sales by Country (in Million US$), 2017-2022
Table 7: Global: Biopharmaceutical Market Forecast: Sales by Country (in Million US$), 2023-2028
Table 8: Global: Biopharmaceutical Market: Sales by Indication (in Billion US$), 2022
Table 9: Mode of Administration of Popular Biotech Drugs